BioFlyte Raises $6.1M in Series A Financing

BioFlyte, an Albuquerque, NM-based biodetection company, raised $6.1M in Series A funding.

The round was led by Cottonwood Technology Fund with participation from existing investor Anzu Partners. David Blivin, Managing Partner of Cottonwood Technology Fund, and Mrs. Jenna Abelli, Principal at Anzu Partners, will join BioFlyte’s Board of Directors.

The company intends to use the funds to support field validation and the initial production of its BioTOF™ z200, a first-of-its-kind, comprehensive biothreat solution for critical infrastructure.

Led by Michael McLoughlin, Executive Chairman, BioFlyte is a biodefense and microbial identification company that is commercializing a new class of fieldable biological contamination sampling, detection, and identification solutions. The firm’s current application focus is critical infrastructure protection and pandemic response.

The BioTOF z200 is a miniaturized, low-cost, and low-power bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments such as third-party command control systems and architectures. The system consists of a wall mount sensor capable of the autonomous detection and identification of airborne microbes and toxins in real-time. It incorporates matrix-assisted laser desorption and ionization (MALDI) mass spectrometry to acquire a mass spectrum from each collected aerosol sample. The BioTOF offers high sensitivity at 100 threat particles per liter of ambient air.